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Propositions accompanying the thesis
CLINICAL and MOLECULAR ASPECTS of 
NUCLEAR THYROID HORMONE ACTION
1. RTHα leads to a phenotype with hypothyroid features in specific tissues.
(This thesis)
2. Treatment of RTHα patients with LT4, especially at young age, can improve 
the clinical phenotype. (This thesis)
3. RTHα patients generally have low (F)T4, high T3, low rT3, but normal TSH 
levels, which suggests an abnormal deiodinase activity in RTHα patients.
(This thesis)
4. The regulation of type 3 deiodinase activity by T3 is differently regulated in 
brain versus liver. (This thesis)
5. TH transporters have a stronger effect on intracellular metabolism of TH 
than on its genomic action in in vitro systems, which may be related to the 
intracellular distribution of TH. (This thesis)
6. Whole genome sequencing leads to a better understanding of human 
genetic variation. (The 1000 Genomes Project Consortium, Nature 2015)
7. Security safeguards are necessary for participants to share their data. (M. 
Mello, N Engl J Med 2018)
8. Patients prefer shared decision making to a certain extent, especially when 
they have a serious illness or if they are older. (J.J. Mira, Health Expect 2014)
9. In the near future, doctors will also use the information of wearable sensors 
in medical decisions. (X. Li, Plos Biology 2017)
10. To improve the Dutch healthcare, the registration burden must be reduced.
(A.R. Schuurman, NTVG 2018)
11. De zin van het leven die schrijf je zelf. (Loesje) 
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